95406-76-1Relevant articles and documents
NOVEL IMIDAZOLE COMPOUND AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONIST
-
Paragraph 0542, (2018/10/04)
The present invention relates to a novel imidazole compound or a pharmaceutically acceptable salt thereof having a melanocortin receptor agonistic activity, and medical use thereof. The present invention relates to an imidazole compound represented by general formula [I] [wherein: Ring A represents an optionally substituted aryl group or the like; R1 represents a hydrogen atom, an optionally substituted alkyl group, or the like; R2 represents a hydrogen atom, a halogen atom, or the like; and R3 represents an optionally substituted alkyl group] or a pharmaceutically acceptable salt thereof.
Ibotenic Acid Analogues. Synthesis, Molecular Flexibility, and in Vitro Activity of Agonists and Antagonists at Central Glutamic Acid Receptors
Lauridsen, Joern,Honore, Tage,Krogsgaard-Larsen, Povl
, p. 668 - 672 (2007/10/02)
The syntheses of (RS)-α-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionic acid (9, ATPA), (α-RS,β-RS)-α-amino-β-methyl-3-hydroxy-5-isoxazolepropionic acid (8), (RS)-α-amino-3-hydroxy-5-isoxazolebutyric acid (15a), and (RS)-α-amino-3-hydroxy-5-isoxazoleval
